New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
—Los Angeles Times, September 2015
Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.
The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:
|...and much more!|
Clinical Research Track
Rick Doblin, Ph.D.
The Future of Psychedelic Therapy
Albert Garcia-Romeu, Ph.D.
Optimizing Psilocybin Dosing for Clinical Precision: The Case for Weight-Adjusted Dosing
Roland Griffiths, Ph.D.
Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience, Adverse Effects, Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients
Stan Grof, M.D.
The Implications of Consciousness Research for Psychiatry, Psychology, and Psychotherapy
Breakthroughs in Psychedelic Research from the Beckley Foundation
Matthew W. Johnson, Ph.D.
Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond
David Nichols, Ph.D.
David Nutt, M.D.
Psychedelic Research at the Beckley/Imperial Research Programme
Stephen Ross, M.D., and Gabby Agin-Liebes, Ph.D. Candidate
Psilocybin for Cancer-Related Anxiety and Depression: NYU Phase 2 Randomized Controlled Trial and Proposed Mechanisms
Interdisciplinary Research Track
Elena Argento, Ph.D. Candidate
Psychedelic Use Predicts Reduced Suicidality: Findings From a Longitudinal Study of Women Sex Workers in Vancouver, Canada
Erika Dyck, Ph.D.
Who is Keeping Tabs? LSD Lessons from the Past
James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Preliminary Results from Psychedelic Microdosing Study
Kevin Franciotti, M.A.
The Use of Psychedelics in the Treatment of Psychotic Disorders
John Hartberg, B.Sc., M.D. Candidate
Ketamine’s Therapeutic Potential: Practical Considerations for Clinical Use
Katherine Hendy, Ph.D.
The Placebo Paradox
Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics
Elizabeth M. Nielson, Ph.D.
Psychedelic Therapists: Perspectives on the Therapeutic Process in Psilocybin Assisted Therapy
Neiloufar Family, Ph.D
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Low Dose LSD: A Phase 1 Study
Milan Scheidegger, M.D., Ph.D., M.A. HPK
Psilocybin Enhances Mindfulness-Related Capabilities in a Meditation Retreat Setting: A Double-Blind Placebo-Controlled fMRI Study
Emmanuelle A. D. Schindler, M.D., Ph.D.
Indoleamine Hallucinogens in the Treatment of Cluster Headache
Thomas Cody Swift, M.A., and Alexander Belser, Ph.D. Candidate
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress
Tomas Palenicek, M.D., Ph.D.
The Effects of Psilocybin on Perception and the Dynamics of Induced EEG/fMRI Correlates of Psychedelic Experience
Plant Medicine Track
Organized by Bia Labate, Ph.D.
Christina Callicott, M.A.
Ethnomedicine Among the Lamista Quechua: History, Innovation and Cultural Revitalization
José Carlos Bouso, Ph.D.
What Do the Spirits Do? Towards an Understanding of the Psychological Mechanisms of Transformation
Clancy Cavnar, Psy.D.
An Examination of Psychological Healing with Ayahuasca
Wendy Chapkis, Ph.D.
Medical Marijuana in a Recreational Age
Benjamin De Loenen, M.A.
Ayahuasca Legal Prosecution Worldwide: Connecting the Dots
Martin Fortier, Ph.D. Candidate
The Sense of Reality in Hallucinogenic Experiences: A Comparative Study of Serotoninergic and Anti-Cholinergic Plants
Alex K. Gearin, Ph.D.
Ayahuasca and the “Diet”: Some Cross-Cultural Considerations
Paul Glue, M.D., FRC Psych
Ibogaine and Opioid Withdrawal: Does it Work and Is it Safe?
J. Hamilton Hudson, J.D.
Bubbling with Controversy: Legal Issues of Ayahuasca Churches in the USA
Thomas Kingsley Brown, Ph.D.
Examining the Psyche in Ibogaine Treatment for Addiction
Anja Loizaga-Velder, Ph.D.
Evaluating the Efficacy of Ayahuasca Assisted Treatment for Substance Dependency
Diana Negrín, Ph.D.
Peyote Dreams: From Collective Ritual to Personal Treatment?
Raven Renèe Ray, M.A.
Ayahuasca Treatment Center Safety for the Western Seeker
Bruno Rasmussen Chaves, M.D.
Ibogaine in Brazil: Finally Stepping out from the Underground?
Stevens Rehen, Ph.D.
Biological Effects of Ayahuasca in Human Neural Stem Cells and Minibrains
Sidarta Ribeiro, Ph.D.
Whole Organisms or Pure Compounds? Entourage Effect versus Drug Specificity
Healing Encounters: Ayahuasca and the Politics of Knowledge
Constanza Sánchez Avilés, Ph.D.
Ayahuasca Practices as Intangible Cultural Heritage: A New Piece in the Drug Policy Puzzle?
Stacy B. Schaefer, Ph.D.
Peyote: Plant Medicine for the Body, Mind, and Soul
Scott Shannon, M.D., ABIHM
Cannabidiol in the Treatment of Anxiety: A Large Case Series
Jordan Sloshower, M.D.
Integrating Plant Medicines and Psychiatry: Theory and Methods of a Model Clinic
Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace
Joanna Steinhardt, M.A., Ph.D. Candidate
Psychedelic Naturalism: Psilocybin and the Evolution of Amateur Applied Mycology